Luci David P
- SEC CIK
- 0001271123
No open-market purchases or sales filed in the past year.
Current role at each company
- ACXP Acurx Pharmaceuticals, Inc.President and CEOas of Apr 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Luci David P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2025 (view filing) | Jan 6 | 2 days | Luci David PPresident and CEO | PPurchase | +49.3K | $1.02 | +$50.2K | +4.7%1.10M after | |
| Jan 8, 2025 (view filing) | Jan 6 | 2 days | Luci David PPresident and CEO | PPurchase | +49.3K | $0.00 | $0 | –49.3K after | Derivative |
| Jul 29, 2022 (view filing) | Jul 27 | 2 days | Luci David PPresident and CEO | PPurchase | +19.7K | $3.80 | +$75.0K | +2.0%1.03M after | |
| Jul 29, 2022 (view filing) | Jul 27 | 2 days | Luci David PPresident and CEO | PPurchase | +39.5K | $0.00 | $0 | –19.7K after | Derivative2 lots |
| Nov 22, 2021 (view filing) | Nov 19 | 3 days | Luci David PPresident and CEO | PPurchase | +5.20K | $4.80 | +$25.0K | +0.5%1.01M after |